Glioma stem cells (GSCs) are a vital element contributing to treatment resistance in GBM, and multiple investigations have shown that HSP90AA1 (Heat Shock Protein 90 Alpha Family Class A Member 1) inhibitors successfully induce cell death in GSCs. This evidence concerns the gene HSP90AA1 and central nervous system cancer.